Similarly, CDK6 demonstrated r>0.7 in only 4 cancers (glioblastoma, head and neck cancer, lung adenocarcinoma, and lung squamous cancer) while IGF1R had r>0.7 in only one cancer (breast cancer) (Figure 3–4). Here, IGF1R is linked to glioblastoma.